Loading...
Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam
PURPOSE: Neoadjuvant regimens containing trastuzumab and chemotherapy were widely used in human epidermal growth factor 2 (HER2) positive breast cancer patients. In this article, we report complete pathological response (pCR) rates from a single institution in Vietnam. PATIENTS AND METHODS: Medical...
Na minha lista:
| Udgivet i: | Breast Cancer (Dove Med Press) |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7549132/ https://ncbi.nlm.nih.gov/pubmed/33116813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S268369 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|